Injective (INJ) Price Today: Breakout From the $12.45 Resistance Zone

After a powerful breakout from the $12.45 resistance zone, the Injective price today is trading around $14.60, registering an intraday gain of over 3.7%.

The Injective price today is trading around $14.60, showing an intraday gain of over 3.7%. This surge marks a strong continuation from last week’s bullish reversal, with momentum firmly on the side of the bulls as INJ clears major technical barriers and reclaims a key Fibonacci level.

While the current rally reflects renewed investor interest, the short-term outlook hinges on whether bulls can maintain control above this breakout threshold or if volatility will trigger a consolidation before any attempt at $15. The market structure now shows a continuation pattern, supported by a series of higher highs and higher lows, confirming a short-term trend reversal.

What’s Happening With Injective’s Price?

The Injective price action over the last 48 hours confirms a textbook breakout from the descending wedge seen on the daily chart. The move came with solid volume expansion, pushing price above the 0.236 Fib retracement level at $12.44 and slicing through $13.50 with ease. Price is now consolidating just under the 100% retracement mark at $14.33.

On the 4-hour timeframe, the structure appears robust, with the price supported by rising EMAs and a well-respected trendline originating from the May 7 low near $8.50. The 20 EMA has just crossed above the 100 EMA, confirming a bullish realignment.

Why Is Injective Price Going Up Today?

The question is: why Injective price going up today? The answer lies in the confluence of bullish technicals and broader market recovery.

The upside breakout aligns with strength across the altcoin market, particularly in the DeFi segment. INJ, which powers the Injective Protocol’s decentralized trading infrastructure, has been gaining investor interest amid rising on-chain activity and TVL metrics.

In addition, the price surge follows a successful retest of the 50% Fibonacci retracement zone at $10.33 earlier this month, setting the stage for a reversal. The RSI (Relative Strength Index) is trending upwards above 58 on the 30-minute chart, indicating sustained buying interest, while MACD maintains a bullish crossover with increasing histogram bars.

Injective Price Volatility Signals Incoming Shift

Despite the current uptrend, the Injective price volatility remains elevated, with Bollinger Bands on the 4-hour chart widening sharply. This suggests that the market could witness rapid price changes in either direction, especially if INJ fails to hold above the critical $14.33 zone.

Ichimoku Cloud analysis on the 1-day and 30-minute charts shows price trading well above the cloud, signaling clear bullish momentum. However, Chande Momentum Oscillator has started to diverge downwardly from the price, hinting at early-stage exhaustion.

That said, as long as bulls can protect the $13.80–$14.00 zone, the broader bias remains tilted to the upside.

Short-Term Forecast: Is $16 Next?

If INJ can sustain above $14.33 on the daily close, the next Fibonacci projection lies between $16.00 and $16.60, a region last tested in early February. On the flip side, failure to hold above $13.80 could invite a corrective dip toward $12.80 and potentially the 20-day EMA around $12.10.

Here’s a summary of the key levels for the near term:

As of now, Injective price update shows a strong bullish structure backed by healthy volume, favorable indicator signals, and broader altcoin participation. A daily close above $14.90 will likely open the gates for further Injective price spikes toward $16.

Still, traders should remain alert to short-term Injective price volatility around current levels as momentum cools. A break below $13.50 could signal a short-lived bull trap—but until then, bulls have the upper hand.

The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.